


IPO9

Anti-IPO9 Products
- Human Anti-IPO9 Recombinant Soluble TCR (clone JH11) (scTCR-0574YC-S(P))
-
- Epitope: FSSDVLNLV
- MHC: HLA-A2
- Recombinant Human Anti-IPO9 Soluble TCR (JH11) (ZIP-Fos/ZIP-Jun) (VS-0622-YF1875)
-
- Epitope: FSSDVLNLV
- MHC: HLA-A2
- Recombinant Human Anti-IPO9 Soluble TCR (JH11) (C-Cys) (VS-0622-YF4583)
-
- Epitope: FSSDVLNLV
- MHC: HLA-A2
- Recombinant Human Anti-IPO9 Soluble TCR (JH11) (KIH) (VS-0622-YF7291)
-
- Epitope: FSSDVLNLV
- MHC: HLA-A2
- Anti-IPO9 Immunohistochemistry Kit (VS-0525-XY3576)
-
- Species Reactivity: Human
- Target: IPO9
- Application: IHC
-
- Derivation: Phage display library screening
- Species Reactivity: Human
- Type: IgG
- Application: FC, ICC/IF, IHC-P, IP, WB
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Transporters
Intracellular
Low cell type specificity
Low immune cell specificity
Low cell line specificity
Interacts with histones H2A, H2B, H3 and H4 (PubMed:11823430, PubMed:30855230). The binding is coupled to RanGTP cycles (PubMed:11823430). Interacts with AKIRIN2; promoting association with pre-assembled proteasomes (PubMed:34711951). Associates with pre-assembled proteasomes; interaction is indirect and mediated via interaction with AKIRIN2 (PubMed:34711951). Interacts with PPP2R1A and PPP2R1B (PubMed:12670497).